MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Arthritis & Rheumatism
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

478 results · 1 filter active ·
Results by year
20002019
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
478 works in the cohort · of 4,299,418page 7 of 10

Labels cover 1 of 478 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 478 of 478 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Hearing loss in Muckle‐Wells syndrome
Jasmin Kuemmerle‐Deschner, Assen Koitschev, Katharina Ummenhofer, Sandra Hansmann, Stefan K. Plontke, Christiane Koitschev +3 more
2012· article· en· Arthritis & Rheumatism· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
70
citations
affunlabeled
Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial
Paul P. Tak, Philip J. Mease, Mark C. Genovese, Joel M. Kremer, Boulos Haraoui, Yoshiya Tanaka +6 more
2012· article· en· Arthritis & Rheumatism· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
66
citations
affunlabeled
Oral treatment with PD‐0200347, an α<sub>2</sub>δ ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes
Christelle Boileau, Johanne Martel‐Pelletier, Julie Brunet, Ginette Tardif, Denis J. Schrier, Craig M. Flory +3 more
2005· article· en· Arthritis & Rheumatism· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
60
citations
affunlabeled
Matrix homeostasis in aging normal human ankle cartilage
Matthias Aurich, A. Robin Poole, A Reiner, Christine Mollenhauer, Arkady Margulis, Klaus E. Kuettner +1 more
2002· article· en· Arthritis & Rheumatism· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
59
citations
affunlabeled
Risk factors for severe Muckle‐Wells syndrome
Jasmin Kümmerle‐Deschner, Pascal N. Tyrrell, Fabian Reess, Ina Kötter, Peter Lohse, Hermann Girschick +6 more
2010· article· en· Arthritis & Rheumatism· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
54
citations

How this was built: Screen · Findings · About